| Product Code: ETC11626081 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The colorectal cancer drugs therapeutic import shipments to the Philippines in 2024 saw significant contributions from top exporting countries including Indonesia, Singapore, Italy, USA, and Spain. Despite a high concentration with a high Herfindahl-Hirschman Index (HHI) in 2024, the market demonstrated a strong compound annual growth rate (CAGR) of 10.62% from 2020 to 2024. However, there was a notable decline in growth rate from 2023 to 2024 at -17.44%, indicating potential shifts in market dynamics that warrant further analysis and monitoring.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Colorectal Cancer Drugs Therapeutic Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Colorectal Cancer Drugs Therapeutic Market - Industry Life Cycle |
3.4 Philippines Colorectal Cancer Drugs Therapeutic Market - Porter's Five Forces |
3.5 Philippines Colorectal Cancer Drugs Therapeutic Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Philippines Colorectal Cancer Drugs Therapeutic Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Philippines Colorectal Cancer Drugs Therapeutic Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Philippines Colorectal Cancer Drugs Therapeutic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of colorectal cancer in the Philippines |
4.2.2 Growing awareness about early detection and treatment options |
4.2.3 Advancements in pharmaceutical research leading to the development of more effective drugs |
4.3 Market Restraints |
4.3.1 High cost associated with colorectal cancer drugs |
4.3.2 Limited access to advanced treatments in certain regions of the Philippines |
4.3.3 Regulatory challenges and approval processes for new drugs |
5 Philippines Colorectal Cancer Drugs Therapeutic Market Trends |
6 Philippines Colorectal Cancer Drugs Therapeutic Market, By Types |
6.1 Philippines Colorectal Cancer Drugs Therapeutic Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Philippines Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Drug Class, 2021 - 2031F |
6.1.3 Philippines Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.1.4 Philippines Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Chemotherapy, 2021 - 2031F |
6.1.5 Philippines Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Philippines Colorectal Cancer Drugs Therapeutic Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Philippines Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Oral, 2021 - 2031F |
6.2.3 Philippines Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.2.4 Philippines Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Intramuscular, 2021 - 2031F |
6.2.5 Philippines Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Subcutaneous, 2021 - 2031F |
6.2.6 Philippines Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Others, 2021 - 2031F |
6.3 Philippines Colorectal Cancer Drugs Therapeutic Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Philippines Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.3.3 Philippines Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.3.4 Philippines Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
7 Philippines Colorectal Cancer Drugs Therapeutic Market Import-Export Trade Statistics |
7.1 Philippines Colorectal Cancer Drugs Therapeutic Market Export to Major Countries |
7.2 Philippines Colorectal Cancer Drugs Therapeutic Market Imports from Major Countries |
8 Philippines Colorectal Cancer Drugs Therapeutic Market Key Performance Indicators |
8.1 Patient survival rate after treatment |
8.2 Adoption rate of new treatment modalities |
8.3 Rate of early-stage colorectal cancer detection |
8.4 Patient adherence to prescribed medication |
8.5 Frequency of clinical trials and research collaborations in the Philippines |
9 Philippines Colorectal Cancer Drugs Therapeutic Market - Opportunity Assessment |
9.1 Philippines Colorectal Cancer Drugs Therapeutic Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Philippines Colorectal Cancer Drugs Therapeutic Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Philippines Colorectal Cancer Drugs Therapeutic Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Philippines Colorectal Cancer Drugs Therapeutic Market - Competitive Landscape |
10.1 Philippines Colorectal Cancer Drugs Therapeutic Market Revenue Share, By Companies, 2024 |
10.2 Philippines Colorectal Cancer Drugs Therapeutic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |